Correlation Engine 2.0
Clear Search sequence regions

  • apoptosis (5)
  • cardiac function (6)
  • factor (2)
  • heart (9)
  • heart disease (1)
  • HO1 (2)
  • intracellular (1)
  • male (1)
  • map (1)
  • mice (2)
  • mitogen (2)
  • NF E2 (2)
  • nfe2l2 protein (1)
  • NQO1 (2)
  • Nrf2 (4)
  • oxygen (6)
  • p38 (2)
  • p38 (3)
  • p38MAPK (3)
  • patients (1)
  • protein kinases (2)
  • sb203580 (1)
  • signal (1)
  • species (6)
  • Sizes of these terms reflect their relevance to your search.

    Radiation-induced heart damage (RIHD) is now considered to be one of the causes of mortality in cancer patients undergoing radiotherapy. Cardiac function impairments are clinical manifestations of RIHD. L-carnitine shows protective effects against irradiation and heart disease. This study was aimed to investigate the cardioprotective effects and potential molecular mechanisms of L-carnitine against RIHD. Mouse hearts were exposed to γ-radiation to induce RIHD. L-carnitine at doses of 100mg/Kg and 200mg/Kg was used to treat animals intraperitoneally. Additionally, a specific inhibitor of p38 MAPK was used to treat animals by intraperitoneal injections. Cardiac systolic/diastolic functions were determined using invasive hemodynamic methods; myocyte apoptosis was assessed using the TUNEL assay; intracellular reactive oxygen species production was measured using DHE staining; and western blotting was used to evaluate the phosphorylation of p38MAPK, phosphorylation of Nrf2, and expression levels of HO1, NQO1, caspase3 and bax. L-carnitine treatments inhibited irradiation induced cardiac function impairments. Radiation exposure induced myocyte apoptosis and reactive oxygen species production, which were attenuated by L-carnitine treatments. However, administration of a p38 MAPK inhibitor (SB203580) dramatically impaired L-carnitine's effect on attenuating apoptosis, reactive oxygen species accumulation and cardiac functions in irradiated hearts. Our study showed that L-carnitine administration activated p38MAPK/Nrf2 signalling, initiating the expression of HO1 and NQO1, which have anti-apoptotic and anti-oxidative effects, respectively. In conclusion, L-carnitine attenuates cardiac function loss by inhibiting reactive oxygen species production and apoptosis in hearts exposed to radiation. The cardioprotective effects of L-carnitine were mediated by p38MAPK/Nrf2 signalling. Copyright © 2017 Elsevier B.V. All rights reserved.


    Zhigang Fan, Yang Han, Yuanpeng Ye, Chao Liu, Hui Cai. l-carnitine preserves cardiac function by activating p38 MAPK/Nrf2 signalling in hearts exposed to irradiation. European journal of pharmacology. 2017 Jun 05;804:7-12

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 28392465

    View Full Text